Image

Global Klinefelter Syndrome Treatment Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Klinefelter Syndrome Treatment Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Klinefelter Syndrome Treatment Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 1.08 USD Billion
Diagram Market Size (Forecast Year) USD 1.54 USD Billion
Diagram CAGR %

Major Markets Players

  • Hoffmann
  • La Roche
  • Takeda Pharmaceutical Company Limited
  • Kyowa Kirin Co. Ltd
  • Pfizer

Global Klinefelter Syndrome Treatment Market, By Treatment (Testosterone Replacement Therapy, Fertility Treatment, Surgeries, Hormone Treatment, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others) – Industry Trends and Forecast to 2030.

Klinefelter Syndrome Treatment Market

Klinefelter Syndrome Treatment Market Analysis and Size

According to the records of National Human Genome Research Institute, Klinefelter syndrome is found in around 1 out of every 500-1,000 newborn males. According to the researchers of national human research institutes, the syndrome cannot be diagnosed easily because of its unidentifiable symptoms and signs among males. There is no definitive treatment, though treatment is offered on the basis of symptoms in the patients. The treatment is provided for psychosocial problems and treatment of gynecomastia and hypogonadism, among others.

Data Bridge Market Research analyses a growth rate in the global klinefelter syndrome treatment market in the forecast period 2023-2030. The expected CAGR of global klinefelter syndrome treatment market tends to be around 4.46% in the mentioned forecast period. The market was valued at USD 1.08 billion in 2022, and it would grow to USD 1.54 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Klinefelter Syndrome Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Treatment (Testosterone Replacement Therapy, Fertility Treatment, Surgeries, Hormone Treatment, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, and Others)

Countries Covered

U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Hoffmann-La Roche Ltd. (Switzerland), Takeda Pharmaceutical Company Limited (Japan), Kyowa Kirin Co., Ltd (Japan), Pfizer Inc (U.S., AstraZeneca (U.K.), Abbvie, Inc. (U.S.), Bausch Health Companies Inc. (U.S.)., Bristol Myers Squibb Company (U.S.) GSK Plc. (U.S.), Mylan N.V. (U.S.), Novartis AG (Switzerland), AstraZeneca (U.K.)

Market Opportunities

  • Increase in the number of research and development activities   
  • The emergence of new varied treatments

Market Definition

Klinefelter syndrome, also known as 47, XXY, is a genetic disorder where you have an extra X chromosome. This common chromosome disorder affects around one in five hundred people. Many people with Klinefelter syndrome never get diagnosed, though. The symptoms vary differently among patients, but few have no apparent signs of the disease. This syndrome may cause reduced muscle mass, body and facial hair, and enlarged breast tissue.

Global Klinefelter Syndrome Treatment Market Dynamics

Drivers

  • Increasing prevalence of Klinefelter syndrome

Klinefelter syndrome is considered the most common type of human sex chromosome disorder. It occurs in around 1 in every 500 to 1,000 males. Furthermore, every year, over 3,000 boys are born in the U.S. with this syndrome. This contributes to the growth of the market.

  • The growing change of changing lifestyles

The trending changing lifestyles of the people, leading to the increase in pregnancy rate after age 35, surges the risk of occurrence of Klinefelter syndrome. This would create demand for its treatment, helping drive the Klinefelter syndrome treatment market.

Opportunities

  • Increase in the number of product approvals       

The increased in focus of Klinefelter syndrome treatment market players on the development of newer products for the treatment of Klinefelter syndrome and major product approvals in the past few years have boosted the market's growth. For instance, in March 2019, Clarus Therapeutics received U.S. FDA approval for Jatenzo, an oral testosterone capsule that would help treat hypogonadism in Klinefelter syndrome patients. Furthermore, in April 2019, the U.S. FDA approved the marketing of a generic testosterone gel 1.62% developed by Lupin. This would help as a replacement therapy for men having hypogonadism.

  • The emergence of new varied treatments

The new evolving research organizations in the market are equipped with and utilize the knowledge of professionals in numerous clinical disciplines, leading to important advances in understanding Klinefelter-related disorders and treatment. For instance, Testosterone replacement therapy can also help with bone density, fracture prevention, and mood and behavior. It also corrects androgen deficiency, promoting body proportion normalization and the development of normal male secondary sex characteristics.

Restraints/Challenges

  • Limited treatment options

Not all males with XXY conditions can be benefitted from testosterone therapy. For instance, the benefits of taking testosterone for men whose testosterone levels are low to normal are less clear than for those whose testosterone levels are extremely low. Additionally, all possible side effects are acne, skin rashes from patches or gels, breathing issues, and an increased risk of an enlarged prostate gland or prostate cancer as you get older. Thus, this factor acts as a major hindrance to market growth.

  • High cost of treatment

The huge expenditure required for the treatment processes hampers the market growth. Numerous market players make huge investments in developing new and advanced treatment procedures to faster the recovery process, and in return, the cost is increased.

This global Klinefelter syndrome treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global Klinefelter syndrome treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Klinefelter Syndrome Treatment Market

COVID-19 infection was common in 10% of Klinefelter syndrome patients. The presence of an extra X chromosome in all infected patients leads to mild symptoms as the presence of an extra X chromosome influences a better clinical outcome. The development of infection was not protected by testicular atrophy. SARS-CoV-2 infection was majorly associated with the presence of one affected cohabitant. The link between SARS-CoV-2 and hypogonadism was confirmed, but the formulation of the TRT was unimportant. Therefore, COVID-19 is expected to impact market growth positively.

Global Klinefelter Syndrome Treatment Market Scope

The global klinefelter syndrome treatment market is segmented on the basis of treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Testosterone Replacement Therapy
  • Fertility Treatment
  • Surgeries
  • Hormone Treatment
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies
  • Others

Klinefelter Syndrome Treatment Market Regional Analysis/Insights

The global klinefelter syndrome treatment market is analysed and market size insights and trends are provided by treatment, distribution channel and end-user as referenced above.

The major countries covered in the global klinefelter syndrome treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market in the forecast period due to the growing production of testosterone in the region's developing countries.

Asia-Pacific is considered to grow over the coming years due to people's increased understanding of the Klinefelter syndrome condition.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Klinefelter Syndrome Treatment Market Share Analysis

The global klinefelter syndrome treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global klinefelter syndrome treatment market

Key players operating in the global klinefelter syndrome treatment market include:

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Kyowa Kirin Co., Ltd (Japan)
  • Pfizer Inc (U.S.)
  • AstraZeneca (U.K.)
  • Abbvie, Inc. (U.S.)
  • Bausch Health Companies Inc. (U.S.).
  • Bristol Myers Squibb Company (U.S.)
  • GSK Plc. (U.S.
  •  Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • AstraZeneca (U.K.)  


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The klinefelter syndrome treatment market size will be worth USD 1.54 billion by 2030.
The growth rate of the klinefelter syndrome treatment market is 4.46% in the forecast period by the year 2030.
Major companies in the klinefelter syndrome treatment market are Hoffmann-La Roche Ltd. (Switzerland), Takeda Pharmaceutical Company Limited (Japan), Kyowa Kirin Co., Ltd (Japan), Pfizer Inc (U.S., AstraZeneca (U.K.), Abbvie, Inc. (U.S.), Bausch Health Companies Inc. (U.S.)., etc.
Treatment, distribution channel and end-user are the factors on which the klinefelter syndrome treatment market research is based.
The increasing prevalence of Klinefelter syndrome and the growing change of changing lifestyles are the growth drivers of the klinefelter syndrome treatment market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials